---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-037450"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2026-09-23T21:08:31+00:00"
generated_at: "2026-09-23T21:10:14.880890+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne shareholders approve Merck KGaA acquisition; HSR waiting period expired

## Summary
- Merger Agreement approved: 121,929,544 for, 1,208,817 against, 30,610 abstaining.
- Non-binding advisory compensation vote failed: 25,912,275 for, 96,412,306 against.
- HSR waiting period expired Sept 18, 2026; closing expected late 2026/early 2027.
- CEO Kim Kelderman cites 'strong support' and near-term cash value for shareholders.

## SEC filing metadata
- accession: 0001140361-26-037450
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2026-09-23T21:08:31+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000114036126037450/0001140361-26-037450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000114036126037450/ef20082601_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-037450
- JSON: https://secwatch.observer/filing/0001140361-26-037450.json
- Plain text: https://secwatch.observer/filing/0001140361-26-037450.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.